Omar El-Taji

Dec 12, 2024 | europeanurology.com | Omar El-Taji |Noel W. Clarke

Platinum Priority – Editorial | Referring to the article published on pp. 15–26 of this issueVolume 87, Issue 1p27-28The Christie and Salford Royal Hospitals, Manchester, UKPublication History:Accepted October 7, 2024DOI: 10.1016/j.eururo.2024.10.005Also available on ScienceDirectCopyright: © 2024 Published by Elsevier B.V. on behalf of European Association of Urology. Get full text accessLog in, subscribe or purchase for full access. ReferencesAziz MK, Molony D, Monlezun D, et al.

Jun 6, 2024 | jamanetwork.com | Omar El-Taji |Samih Taktak |Craig Jones |Mick Brown

Cardiovascular Risk in Prostate Cancer—A Call to Action?

Jun 6, 2024 | jamanetwork.com | Omar El-Taji |Craig Jones |Mick Brown |Noel W. Clarke

Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer: A Systematic Review and Meta-Analysis Key PointsQuestion  Are androgen receptor signaling inhibitors associated with increased risk of cardiovascular events in men with advanced and metastatic prostate cancer?